Mean concentrations of MMP-3 were significantly higher in patients with metastatic prostate cancer as compared with those with non-metastatic cancer, patients with benign prostate hyperplasia, and healthy controls [16]. The gene discussed is MMP3; the disease is metastatic malignant neoplasm.